
    
      Participants who were randomized and received either Menactra速 or Menomune速 vaccine in trial
      MTA29 will receive 1 dose of either Menactra速 or Menomune速, respectively on Day 0 and will be
      followed-up for 28 days post-vaccination.
    
  